Home Stocks ZIVO Zivo Bioscience Inc (NASDAQ: ZIVO) Healthcare · Biotechnology
$5.50
Last close · Nov 17, 2026 · NASDAQ USD
The Quantellect read. Short interest is 0.52% of float with a 16.68% borrow fee. Zero active firms cover the stock as of Nov 19, 2026; zero active firms with targets average $12.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.
Relative valuation Higher multiples than peers P/S 163.7× vs peer median 13.9×
Trend Between the 50- and 200-day averages $5.50 vs $4.88 and $7.30 · as of Nov 17, 2026
Short interest 0.5% of float FINRA settlement Oct 30, 2026
SMA 10 $7.28 SMA 20 $6.20 SMA 50 $4.88 SMA 200 $7.30
Nov 17, 2026 O $5.25 H $5.50 L $5.25 C $5.50 Vol 983
×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date May 18, 2026 ET Last date Nov 17, 2026 ET Open $4.06 High $10.49 Low $3.01 Close $5.50 Volume 80,871 Plotted bars 69
Plotted OHLCV bars May 18, 2026 ET · Open $4.06 · High $4.06 · Low $4.06 · Close $4.06 · Volume 270 May 22, 2026 ET · Open $3.60 · High $4.10 · Low $3.60 · Close $4.10 · Volume 535 May 26, 2026 ET · Open $4.00 · High $4.00 · Low $4.00 · Close $4.00 · Volume 1,004 May 27, 2026 ET · Open $4.60 · High $4.60 · Low $4.60 · Close $4.60 · Volume 109 May 28, 2026 ET · Open $4.40 · High $4.40 · Low $4.40 · Close $4.40 · Volume 469 May 29, 2026 ET · Open $4.40 · High $4.40 · Low $4.40 · Close $4.40 · Volume 1,239 Jun 3, 2026 ET · Open $4.15 · High $4.15 · Low $3.03 · Close $3.72 · Volume 2,032 Jun 5, 2026 ET · Open $3.73 · High $3.73 · Low $3.05 · Close $3.05 · Volume 2,552 Jun 9, 2026 ET · Open $3.38 · High $3.38 · Low $3.38 · Close $3.38 · Volume 140 Jun 12, 2026 ET · Open $3.67 · High $3.67 · Low $3.67 · Close $3.67 · Volume 1,127 Jun 15, 2026 ET · Open $3.69 · High $3.69 · Low $3.69 · Close $3.69 · Volume 834 Jun 23, 2026 ET · Open $3.10 · High $4.30 · Low $3.10 · Close $4.30 · Volume 5,142 Jun 24, 2026 ET · Open $3.70 · High $4.32 · Low $3.68 · Close $4.32 · Volume 1,959 Jun 25, 2026 ET · Open $3.38 · High $3.60 · Low $3.10 · Close $3.15 · Volume 719 Jun 26, 2026 ET · Open $3.50 · High $4.50 · Low $3.50 · Close $4.50 · Volume 992 Jun 29, 2026 ET · Open $4.02 · High $4.21 · Low $4.02 · Close $4.21 · Volume 216 Jun 30, 2026 ET · Open $4.10 · High $4.20 · Low $4.03 · Close $4.03 · Volume 5,997 Jul 1, 2026 ET · Open $4.15 · High $4.28 · Low $4.15 · Close $4.20 · Volume 862 Jul 2, 2026 ET · Open $4.50 · High $5.25 · Low $4.50 · Close $5.25 · Volume 2,015 Jul 6, 2026 ET · Open $3.82 · High $5.25 · Low $3.82 · Close $5.25 · Volume 254 Jul 9, 2026 ET · Open $4.91 · High $4.91 · Low $4.75 · Close $4.75 · Volume 1,205 Jul 10, 2026 ET · Open $4.50 · High $4.83 · Low $3.80 · Close $4.83 · Volume 1,949 Jul 15, 2026 ET · Open $4.34 · High $4.34 · Low $4.34 · Close $4.34 · Volume 402 Jul 16, 2026 ET · Open $4.50 · High $5.00 · Low $4.50 · Close $4.80 · Volume 668 Jul 17, 2026 ET · Open $4.14 · High $4.14 · Low $4.14 · Close $4.14 · Volume 160 Jul 20, 2026 ET · Open $4.08 · High $4.08 · Low $4.08 · Close $4.08 · Volume 137 Jul 21, 2026 ET · Open $4.38 · High $4.38 · Low $4.00 · Close $4.00 · Volume 413 Jul 23, 2026 ET · Open $4.00 · High $5.00 · Low $3.99 · Close $5.00 · Volume 8,156 Jul 28, 2026 ET · Open $4.00 · High $4.00 · Low $4.00 · Close $4.00 · Volume 135 Jul 30, 2026 ET · Open $4.12 · High $4.60 · Low $4.00 · Close $4.00 · Volume 700 Aug 3, 2026 ET · Open $4.85 · High $4.97 · Low $4.00 · Close $4.00 · Volume 575 Aug 6, 2026 ET · Open $4.02 · High $4.02 · Low $4.02 · Close $4.02 · Volume 100 Aug 11, 2026 ET · Open $4.02 · High $4.29 · Low $4.02 · Close $4.29 · Volume 296 Aug 17, 2026 ET · Open $4.07 · High $4.07 · Low $4.05 · Close $4.05 · Volume 699 Aug 19, 2026 ET · Open $3.95 · High $3.95 · Low $3.95 · Close $3.95 · Volume 302 Aug 21, 2026 ET · Open $4.30 · High $4.30 · Low $4.25 · Close $4.25 · Volume 401 Aug 24, 2026 ET · Open $4.32 · High $4.33 · Low $4.27 · Close $4.27 · Volume 2,718 Sep 1, 2026 ET · Open $3.96 · High $3.96 · Low $3.95 · Close $3.95 · Volume 319 Sep 3, 2026 ET · Open $3.95 · High $3.95 · Low $3.60 · Close $3.60 · Volume 1,651 Sep 8, 2026 ET · Open $3.50 · High $3.50 · Low $3.01 · Close $3.11 · Volume 821 Sep 10, 2026 ET · Open $3.33 · High $3.60 · Low $3.33 · Close $3.60 · Volume 510 Sep 11, 2026 ET · Open $3.80 · High $4.15 · Low $3.80 · Close $4.10 · Volume 1,691 Sep 16, 2026 ET · Open $4.00 · High $4.00 · Low $3.35 · Close $3.35 · Volume 1,920 Sep 17, 2026 ET · Open $3.35 · High $3.35 · Low $3.19 · Close $3.19 · Volume 600 Sep 18, 2026 ET · Open $3.20 · High $3.20 · Low $3.20 · Close $3.20 · Volume 201 Sep 21, 2026 ET · Open $3.20 · High $3.20 · Low $3.20 · Close $3.20 · Volume 229 Sep 22, 2026 ET · Open $3.25 · High $3.55 · Low $3.25 · Close $3.55 · Volume 934 Sep 23, 2026 ET · Open $3.80 · High $3.80 · Low $3.51 · Close $3.60 · Volume 1,975 Sep 25, 2026 ET · Open $3.51 · High $3.51 · Low $3.30 · Close $3.30 · Volume 352 Oct 1, 2026 ET · Open $3.35 · High $3.55 · Low $3.35 · Close $3.54 · Volume 1,648 Oct 2, 2026 ET · Open $3.60 · High $4.01 · Low $3.60 · Close $4.01 · Volume 1,145 Oct 5, 2026 ET · Open $3.94 · High $4.15 · Low $3.94 · Close $4.10 · Volume 1,703 Oct 7, 2026 ET · Open $4.10 · High $4.10 · Low $4.10 · Close $4.10 · Volume 201 Oct 8, 2026 ET · Open $4.19 · High $4.30 · Low $4.19 · Close $4.24 · Volume 420 Oct 9, 2026 ET · Open $4.40 · High $5.31 · Low $4.40 · Close $5.30 · Volume 3,905 Oct 13, 2026 ET · Open $6.19 · High $6.51 · Low $6.19 · Close $6.51 · Volume 1,912 Oct 16, 2026 ET · Open $6.91 · High $6.91 · Low $6.50 · Close $6.50 · Volume 1,888 Oct 19, 2026 ET · Open $6.50 · High $6.80 · Low $6.50 · Close $6.80 · Volume 1,046 Oct 22, 2026 ET · Open $6.23 · High $6.23 · Low $6.15 · Close $6.15 · Volume 1,009 Oct 23, 2026 ET · Open $6.25 · High $6.25 · Low $6.25 · Close $6.25 · Volume 153 Oct 28, 2026 ET · Open $7.00 · High $7.25 · Low $7.00 · Close $7.25 · Volume 442 Oct 29, 2026 ET · Open $9.24 · High $9.24 · Low $8.27 · Close $8.59 · Volume 2,134 Oct 30, 2026 ET · Open $8.12 · High $8.12 · Low $8.12 · Close $8.12 · Volume 206 Nov 3, 2026 ET · Open $7.25 · High $7.25 · Low $7.25 · Close $7.25 · Volume 134 Nov 4, 2026 ET · Open $10.49 · High $10.49 · Low $10.49 · Close $10.49 · Volume 130 Nov 5, 2026 ET · Open $8.12 · High $8.12 · Low $8.12 · Close $8.12 · Volume 186 Nov 9, 2026 ET · Open $5.76 · High $5.76 · Low $5.76 · Close $5.76 · Volume 1,692 Nov 16, 2026 ET · Open $5.85 · High $5.99 · Low $5.16 · Close $5.50 · Volume 1,248 Nov 17, 2026 ET · Open $5.25 · High $5.50 · Low $5.25 · Close $5.50 · Volume 983 Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of Nov 18, 2026, 8:49 PM ET
Initial 6M price range summary Range 6M First close $4.06 Last close $5.50 High $10.49 Low $3.01 Volume 80,871
Open $5.25 Historical · Nov 17, 2026
Previous close $5.50 Nov 16, 2026 close
Day range $5.25 – $5.50 Historical · Nov 17, 2026
52-week range $1.17 – $11.95 Through Nov 17, 2026
Volume 529 Historical · Nov 17, 2026
Average volume (30 calendar days, 12 sessions) 780 Through Nov 17, 2026
Market cap $34.23M
P/E (TTM) negative earnings —
Forward P/E —
EPS (TTM) stale vendor snapshot —
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) —
Price history ZIVO · nasdaq · USD
Last completed session: Nov 17, 2026
Split-adjusted · volume in shares
Missing sessions: Nov 2, 2026, Nov 6, 2026, Nov 10, 2026, Nov 11, 2026, Nov 12, 2026, Nov 13, 2026, Nov 18, 2026
November 2026 · 6 completed sessions Date Open High Low Close Change Volume Nov 17 5.25 5.50 5.25 5.50 0.000.00% 983 Open 5.25 High 5.50 Low 5.25 Nov 16 5.85 5.99 5.1625 5.50 — 1,248 Open 5.85 High 5.99 Low 5.1625 Nov 9 5.76 5.76 5.76 5.76 — 1,692 Open 5.76 High 5.76 Low 5.76 Nov 5 8.12 8.12 8.12 8.12 −2.37−22.592946% 186 Open 8.12 High 8.12 Low 8.12 Nov 4 10.49 10.49 10.49 10.49 +3.24+44.689655% 130 Open 10.49 High 10.49 Low 10.49 Nov 3 7.25 7.25 7.25 7.25 — 134 Open 7.25 High 7.25 Low 7.25
Notable price movement Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.
Nov 9
$5.76 −29.06%
Trading volume was 2.0 times the 30-day average, with 1.69K shares traded.
Nov 5
$8.12 −22.59%
Trading volume was 0.2 times the 30-day average, with 186 shares traded.
Nov 4
$10.49 +44.69%
Trading volume was 0.1 times the 30-day average, with 130 shares traded.
Options flow — · Options flow not available
Q Score — · Q Score not available
How ZIVO compares with its industry Against 592 other US-listed Biotechnology stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Strongest pointsOne-month return was 52.8%, higher than 99% of 567 peers.Peer median −13.9% · As of Nov 16, 2026 Latest-quarter year-over-year sales growth was 108.3%, higher than 88% of 592 peers.Peer median 0.0% · As of Nov 17, 2026 Points of cautionCurrent ratio was 0.08, with only 1% of 498 peers reporting a lower value.Peer median 5.03 · As of Nov 17, 2026 Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026 Valuation Higher multiples than peers
Metric ZIVO Peer median
Profitability Profitability metrics are lower than most peers.
Metric ZIVO Peer median
Gross margin 31.7% 78.6%
Not ranked: only 246 of 592 peers report it
Operating margin — 0.0%
Not ranked: only 443 of 592 peers report it
Net margin 0.0% 0.0%
Higher than 19% of 583 peers
Return on equity — −67.9%
Not ranked: only 555 of 592 peers report it
Growth Growth metrics are higher than most peers.
Metric ZIVO Peer median
Quarterly sales growth, year over year 108.3% 0.0%
Higher than 88% of 592 peers
5-year sales growth rate — 11.3%
Not ranked: only 140 of 592 peers report it
Balance sheet Balance sheet metrics are lower than most peers.
Metric ZIVO Peer median
Momentum Returns are mixed versus peers.
Metric ZIVO Peer median
1-year return — −28.4%
Not ranked: only 523 of 592 peers report it
6-month return −46.3% −26.6%
Higher than 31% of 545 peers
3-month return +25.0% −29.9%
Top 10% of peers Higher than 93% of 558 peers
How to read this The dot marks where ZIVO ranks among its peers on each metric, from lowest (left) to highest (right). The tick in the middle marks the peer median.
Green marks a rank in the top 10% of peers, amber the bottom 10%. Valuation and balance-sheet metrics stay neutral because a high rank there is not better or worse.
A metric is ranked only when enough peers report it. Peers exclude this company. Percentages count peers with a strictly lower value; equal values do not count.
Lowest Median Highest
Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 13, 2026
Upcoming events — · Upcoming events not available
Analyst consensus No Coverage
0 Strong Buy
0 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 0 active firms as of Nov 19, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $12.00
Average $12.00
High $12.00
As of Nov 19, 2026 across 0 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 4 quarters −5.00 −4.00 −3.00 −2.00 −1.00 0.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2025 −$0.36 −$0.27 —
Q2 2025 −$0.41 −$0.43 —
Q1 2025 −$0.52 −$1.12 —
Annual 2024 −$0.56 −$4.23 —
Smart-money activity In the last 60 days: 0 insider sales and 0 purchases. No congressional trades in 90 days.
Date Type Who Action Amount Source
Apr 17, 2026 Insider buy STROME MARK E / STROME INVESTMENT MANAGEMENT LP / STROME GROUP, INC. Buy $200K Form 4 Feb 27, 2026 Insider buy YALDOO LAITH L Buy $15.0K Form 4 Feb 12, 2026 Insider buy STROME MARK E / STROME INVESTMENT MANAGEMENT LP / STROME GROUP, INC. Buy $195.4K Form 4 Feb 10, 2026 Insider buy YALDOO LAITH L Buy $25.0K Form 4 Jan 26, 2026 Insider buy Cornell Alison A Buy $100.0K Form 4 Jan 26, 2026 Insider buy PAYNE JOHN BERNARD Buy $100.0K Form 4 Jan 14, 2026 Insider buy Maggiore Christopher D. Buy $15.0K Form 4 Jan 14, 2026 Insider buy YALDOO LAITH L Buy $15.0K Form 4 Nov 28, 2025 Insider buy YALDOO LAITH L Buy $25.0K Form 4 Oct 13, 2025 Insider buy STROME MARK E / STROME INVESTMENT MANAGEMENT LP / STROME GROUP, INC. Buy $250.0K Form 4 All smart-money activity →
News and press releases Year All 2026 Apr 24, 2026, 3:00 AM ET Apr 6, 2026, 8:00 AM ET All ZIVO news → Company profile ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or
CEO Mr. John Bernard Payne
Headquarters Troy, MI, United States
Employees 7
IPO date Sep 24, 2012
Sector Healthcare
Industry Biotechnology Q Score — · Q Score not available
Upcoming events — · Upcoming events not available
Analyst consensus No Coverage
0 Strong Buy
0 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 0 active firms as of Nov 19, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $12.00
Average $12.00
High $12.00
As of Nov 19, 2026 across 0 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 4 quarters −5.00 −4.00 −3.00 −2.00 −1.00 0.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2025 −$0.36 −$0.27 —
Q2 2025 −$0.41 −$0.43 —
Q1 2025 −$0.52 −$1.12 —
Annual 2024 −$0.56 −$4.23 —
Company profile ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or
CEO Mr. John Bernard Payne
Headquarters Troy, MI, United States
Employees 7
IPO date Sep 24, 2012
Sector Healthcare
Industry Biotechnology